MDA Q3_2018 (Eng.) November 7, 2018 Subject : Interim Management Discussion and Analysis of Q3/2018 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements

and Analysis Quarterly Ending September 30, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 4/2018

Ref. POL. 125/2019 November 8th 2019 Re: Clarification of the Performance of S & P Syndicate Public Company Limited Dear The President The Stock Exchange of Thailand S & P Syndicate Public Company

Microsoft Word - MDA Q319 EN.docx November 11, 2019 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent

MD&A Q4_2019 (Eng ) February 19, 2020 Subject : Yearly Management Discussion and Analysis of 2019 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements

Microsoft Word - MD&A Q1_2020 (Eng ) May 8, 2020 Subject : Interim Management Discussion and Analysis of Q1/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the

MD&A Q2_2020 (Eng ) July 31, 2020 Subject : Interim Management Discussion and Analysis of Q2/2020 Attention : President of The Stock Exchange of Thailand We attach herewith the financial statements

Microsoft Word - MDA Q220 EN August 10, 2020 To President The Stock Exchange of Thailand Subject Notification on the difference of revenue from sales and net profit YOY by more than 20 percent

Microsoft Word - Operating Result for the first quarter of 2020 SBN 010/2020 May 14, 2020 Subject : Operating Result for the first quarter of 2020 To : The Managing Director, The Stock Exchange of

August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries